Digest Network Come funziona
Network
/
Società
Sa
Non verificato

Satellos BioScience Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

54 comunicati stampa

Guarda tutti i comunicati
24/02/2026
Eventi
Salute
Biologia
Biotecnologia
Medicina - Varie
Farmaceutica
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
18/02/2026
Web e Social Network
Industria
Eventi
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
17/02/2026
Associazioni/Professionisti
Salute
Biotecnologia
Finanza
Medicina - Varie
Farmaceutica
Eventi
Web e Social Network
Satellos to Participate in Upcoming Investor Conferences
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
12/02/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Industria
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
10/02/2026
Eventi
Web e Social Network
Scienza
Medicina - Varie
Biotecnologia
Sanità
Salute
Farmaceutica
Satellos to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
09/02/2026
Finanza
Associazioni/Professionisti
Salute
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
06/02/2026
Associazioni/Professionisti
Salute
Biologia
Finanza
Medicina - Varie
Farmaceutica
Biotecnologia
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
29/01/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato del lavoro
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
28/01/2026
Biotecnologia
Farmaceutica
Salute
Biologia
Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
09/12/2025
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Medicina - Varie
Biotecnologia
Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0